OPSUMIT for Connective tissue disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where OPSUMIT was used for Connective tissue disorder.
Most Reported Side Effects for OPSUMIT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 52 | 15.3% | 5 | 24 |
| Headache | 33 | 9.7% | 1 | 2 |
| Death | 27 | 8.0% | 27 | 6 |
| Nausea | 21 | 6.2% | 2 | 4 |
| Cough | 19 | 5.6% | 1 | 5 |
| Fluid retention | 19 | 5.6% | 2 | 9 |
| Malaise | 19 | 5.6% | 0 | 6 |
| Nasal congestion | 19 | 5.6% | 0 | 2 |
| Pneumonia | 19 | 5.6% | 9 | 15 |
| Oedema peripheral | 17 | 5.0% | 0 | 7 |
| Pulmonary arterial hypertension | 16 | 4.7% | 10 | 10 |
| Disease progression | 14 | 4.1% | 13 | 8 |
| Fatigue | 13 | 3.8% | 0 | 5 |
| Fluid overload | 13 | 3.8% | 4 | 12 |
| Oedema | 13 | 3.8% | 1 | 6 |
Other Indications for OPSUMIT
Pulmonary arterial hypertension (176)
Product used for unknown indication (73)
Pulmonary hypertension (41)
Cor pulmonale chronic (21)
Cardiac disorder (6)
Portopulmonary hypertension (6)
Other Drugs Used for Connective tissue disorder
AMBRISENTAN (857)
RITUXIMAB (134)
TREPROSTINIL (109)
MACITENTAN (107)
SILDENAFIL (104)
MYCOPHENOLATE MOFETIL (86)
HYDROXYCHLOROQUINE (74)
ETANERCEPT (73)
BOSENTAN (62)
METHOTREXATE (59)